4.8 Article

Exploration of Coding and Non-coding Variants in Cancer Using GenomePaint

期刊

CANCER CELL
卷 39, 期 1, 页码 83-+

出版社

CELL PRESS
DOI: 10.1016/j.ccell.2020.12.011

关键词

-

资金

  1. National Cancer Institute of the NIH [R01CA216391]
  2. Cancer Center Support Grant from the NIH [P30CA021765]
  3. American Lebanese Syrian Associated Charities (ALSAC)

向作者/读者索取更多资源

GenomePaint is an interactive visualization platform that allows in-depth exploration of individual cancer genomes and full cohorts' whole-genome, whole-exome, transcriptome, and epigenomic data, supporting analysis of various types of variants, functional impact exploration, correlation analysis, and custom data upload.
GenomePaint (https://genomepaint.stjude.cloud/) is an interactive visualization platform for whole-genome, whole-exome, transcriptome, and epigenomic data of tumor samples. Its design captures the inter-relatedness between DNA variations and RNA expression, supporting in-depth exploration of both individual cancer genomes and full cohorts. Regulatory non-coding variants can be inspected and analyzed along with coding variants, and their functional impact further explored by examining 3D genome data from cancer cell lines. Further, GenomePaint correlates mutation and expression patterns with patient outcomes, and supports custom data upload. We used GenomePaint to unveil aberrant splicing that disrupts the RING domain of CREBBP, discover cis activation of the MYC oncogene by duplication of the NOTCH1-MYC enhancer in B-lineage acute lymphoblastic leukemia, and explore the inter- and intra-tumor heterogeneity at EGFR in adult glioblastomas. These examples demonstrate that deep multi-omics exploration of individual cancer genomes enabled by GenomePaint can lead to biological insights for follow-up validation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据